Principia Biopharma Announces the Acceptance of Data from Phase 2 Pemphigus Vulgaris Trial as a Late-Breaking Presentation at 2019 American Academy of Dermatology Meeting February 22, 2019 - NASDAQ Companies 0 » View More News for February 22, 2019
